Fort, L.P. Regeneron Pharmaceuticals, Inc. Transaction History

Fort, L.P.

$38.5 Million
Q3 2024

A detailed history of Fort, L.P. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fort, L.P. holds 257 shares of REGN stock, worth $189,666. This represents 0.7% of its overall portfolio holdings.

Number of Shares

257

Previous 288 10.76%

Holding current value

$189,666

Previous $302,000 10.6%

% of portfolio

0.7%

Previous 0.78%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$1024.09 - $1201.76 $31,746 - $37,254	-31 Reduced 10.76%	257 $270,000
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $2,649 - $3,213	3 Added 1.05%	288 $302,000
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $56,869 - $62,581	-63 Reduced 18.1%	285 $274,000
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $13,849 - $16,887	-20 Reduced 5.43%	348 $286,000
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $34,301 - $40,687	-49 Reduced 11.75%	368 $264,000
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $134,056 - $162,913	-197 Reduced 32.08%	417 $342,000
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $71,294 - $77,405	-101 Reduced 14.13%	614 $442,000
Q3 2022 Nov 10, 2022	SELL	$573.97 - $724.32 $118,811 - $149,934	-207 Reduced 22.45%	715 $493,000
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $25,772 - $34,725	47 Added 5.37%	922 $545,000
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $152,350 - $178,798	256 Added 41.36%	875 $611,000
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $265,218 - $327,433	-488 Reduced 44.08%	619 $391,000
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $400,672 - $475,310	-698 Reduced 38.67%	1,107 $670,000
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $409,444 - $483,695	-866 Reduced 32.42%	1,805 $1.01 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $118,383 - $145,273	265 Added 11.01%	2,671 $1.26 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $633,747 - $805,573	1,325 Added 122.57%	2,406 $1.16 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $588,874 - $711,525	1,081 New	1,081 $605,000

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Fort, L.P. with notifications on news.

Account